Kenya Recalls Substandard Antimalarial Drug

Malaria pills (file photo).

An antimalarial drug called Duo-Cotecxin that failed a laboratory quality test has been recalled from the Kenyan market over safety concerns.

Dr Jacinta Wasike, the director of inspection, surveillance and enforcement at the Pharmacy and Poisons Board, told reporters in Kisumu on Thursday that the Board has advised against further importation of the drug.


She said the Board immediately acted on an alert that revealed that the drug of batch number 160621, which is widely in circulation across the country, failed an assay test. It was declared substandard, quarantined and an order issued to withdraw it from pharmacy shelves in Kenya.

"There was this particular batch that raised questions and immediately we placed a quarantine and recalled all the drugs," said Dr Wasike at a press conference in Kisumu.

The drug samples that were purchased from a pharmacy outlet in Nairobi are manufactured by Chinese firm Zhejiang Holley Nanhu Pharmaceutical co. The drugs' expiry date is May 2018.

More to follow.

See What Everyone is Watching

More From: Nation

Don't Miss

AllAfrica publishes around 600 reports a day from more than 140 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.